Apple’s A16 Bionic Was Internally Labeled As A 5nm Chip, But Was Marketed As A 4nm SoC Instead

wccftech.com:

Apple’s marketing team does a phenomenal job in hyping up the positives of its products and chips, even if it means misleading the consumers into believing that they are actually investing in something that is cutting-edge. With the A16 Bionic, there were indications that the chipset fueling the iPhone 14 Pro and iPhone 14 Pro Max was produced on TSMC’s 4nm process, meaning that the flagships would tout incredible power-efficiency attributes. However, according to a new rumor, the chipset was internally labeled as a 5nm part, not a 4nm one.

Despite being displayed as a 4nm part, well-known tipster URedditor shares that the A16 Bionic was referred to as a 5nm chip. This may explain why the M2 Pro and M2 Max, which are found in the updated 14-inch and 16-inch MacBook Pro models, are mentioned in Apple’s press release to be mass produced on the 5nm process instead of the 4nm one. With this revelation, the A17 Bionic could deliver a bigger performance gap thanks to being made on TSMC’s cutting-edge 3nm node.

In a previous benchmark, the A17 Bionic was said to be up to 31 percent faster in single-core and multi-core results compared to its predecessor. The latest information now makes the upcoming iPhone 15 Pro and iPhone 15 Pro Max appear as an enticing upgrade because both of these are said to exclusively ship with the A17 Bionic, while the less expensive iPhone 15 and iPhone 15 Plus will likely be treated with the A16 Bionic.

An interesting tidbit about the A16 - looks like the whole “4nm” thing was apparently a marketing gimmick, I’ve seen it labeled as a 5nm chip internally.

This does not Apply to the A17, that one is undoubtedly 3nm, so it should be a more significant upgrade. https://t.co/GjE8XWcLch

— Unknownz21